BioCentury | Dec 10, 2020
Management Tracks

Ricks takes baton from Caforio at PhRMA; plus Bluestone joins Gilead board and Derrick Li returns to investment banking, joining Baird

...endocrinology at the University of California San Francisco.Derrick Li is returning to investment banking at Robert W. Baird...
...Chicago Pritzker School of Medicine. Carlson was EVP and CSO at Akorn Inc. (NASDAQ:AKRX). Danielle Golovin Gilead Sciences Inc. Robert W. Baird Phagelux...
BioCentury | Dec 12, 2019
Financial News

Momenta, Forty Seven, Assembly push 2019 follow-on tally to $21.5B

...million shares at $16.499 a share. Underwriters were Jefferies, SVB Leerink, William Blair, Mizuho, and Robert W. Baird...
BioCentury | Dec 5, 2019
Financial News

Follow-on Roundup: Arrowhead, Kodiak, Relmada, Revance

...discount from Monday’s close of $63.33. Underwriters were Goldman Sachs, Jefferies, Piper Jaffray, Cantor Fitzgerald, Robert W. Baird...
BioCentury | Apr 5, 2019
Company News

Management tracks: Zealand taps Alnylam’s Dulac as CEO, plus ICER, Jnana and more

...pharmaceutical and specialty pharmaceutical industries. Schechner led biotech, pharmaceutical and pharmaceutical services investment banking at Robert W. Baird...
BioCentury | Nov 9, 2018
Financial News

Sarepta collects half a billion in follow-on

...Underwriters for the follow-on were Goldman Sachs, J.P. Morgan, Credit Suisse, Cowen, William Blair, Robert W. Baird...
BioCentury | Nov 9, 2018
Financial News

Sarepta collects half a billion in follow-on

...Underwriters for the follow-on were Goldman Sachs, J.P. Morgan, Credit Suisse, Cowen, William Blair, Robert W. Baird...
BioCentury | Nov 2, 2018
Financial News

Twist raises $70M in NASDAQ IPO

...$75 million for a valuation of $399.1 million J.P. Morgan, Cowen, Allen & Co. and Robert W. Baird...
BioCentury | Jun 13, 2016
Financial News

Sarepta Therapeutics completes follow-on

...$37.5 million Shares: 2.1 million Price: $17.84 Shares after offering: 47.9 million Underwriters: Credit Suisse; Robert W. Baird WIR...
BioCentury | Jun 10, 2016
Financial News

Sarepta raises $37.5M in follow-on

...Sarepta Therapeutics Inc. (NASDAQ:SRPT) raised $37.5 million in a follow-on underwritten by Credit Suisse and Robert W. Baird...
BioCentury | Oct 12, 2015
Financial News

Sarepta Therapeutics completes follow-on

...million Price: $39 Shares after offering: 44.8 million Underwriters: Credit Suisse; Morgan Stanley; Needham; Oppenheimer; Robert W. Baird...
Items per page:
1 - 10 of 105
BioCentury | Dec 10, 2020
Management Tracks

Ricks takes baton from Caforio at PhRMA; plus Bluestone joins Gilead board and Derrick Li returns to investment banking, joining Baird

...endocrinology at the University of California San Francisco.Derrick Li is returning to investment banking at Robert W. Baird...
...Chicago Pritzker School of Medicine. Carlson was EVP and CSO at Akorn Inc. (NASDAQ:AKRX). Danielle Golovin Gilead Sciences Inc. Robert W. Baird Phagelux...
BioCentury | Dec 12, 2019
Financial News

Momenta, Forty Seven, Assembly push 2019 follow-on tally to $21.5B

...million shares at $16.499 a share. Underwriters were Jefferies, SVB Leerink, William Blair, Mizuho, and Robert W. Baird...
BioCentury | Dec 5, 2019
Financial News

Follow-on Roundup: Arrowhead, Kodiak, Relmada, Revance

...discount from Monday’s close of $63.33. Underwriters were Goldman Sachs, Jefferies, Piper Jaffray, Cantor Fitzgerald, Robert W. Baird...
BioCentury | Apr 5, 2019
Company News

Management tracks: Zealand taps Alnylam’s Dulac as CEO, plus ICER, Jnana and more

...pharmaceutical and specialty pharmaceutical industries. Schechner led biotech, pharmaceutical and pharmaceutical services investment banking at Robert W. Baird...
BioCentury | Nov 9, 2018
Financial News

Sarepta collects half a billion in follow-on

...Underwriters for the follow-on were Goldman Sachs, J.P. Morgan, Credit Suisse, Cowen, William Blair, Robert W. Baird...
BioCentury | Nov 9, 2018
Financial News

Sarepta collects half a billion in follow-on

...Underwriters for the follow-on were Goldman Sachs, J.P. Morgan, Credit Suisse, Cowen, William Blair, Robert W. Baird...
BioCentury | Nov 2, 2018
Financial News

Twist raises $70M in NASDAQ IPO

...$75 million for a valuation of $399.1 million J.P. Morgan, Cowen, Allen & Co. and Robert W. Baird...
BioCentury | Jun 13, 2016
Financial News

Sarepta Therapeutics completes follow-on

...$37.5 million Shares: 2.1 million Price: $17.84 Shares after offering: 47.9 million Underwriters: Credit Suisse; Robert W. Baird WIR...
BioCentury | Jun 10, 2016
Financial News

Sarepta raises $37.5M in follow-on

...Sarepta Therapeutics Inc. (NASDAQ:SRPT) raised $37.5 million in a follow-on underwritten by Credit Suisse and Robert W. Baird...
BioCentury | Oct 12, 2015
Financial News

Sarepta Therapeutics completes follow-on

...million Price: $39 Shares after offering: 44.8 million Underwriters: Credit Suisse; Morgan Stanley; Needham; Oppenheimer; Robert W. Baird...
Items per page:
1 - 10 of 105